Explore insights and strategies for managing ATTR-CM long-term.
-
-
Ventilation abnormalities are key in ATTR-CM exercise limitation, study says
-
How TTR stabilizers work in managing ATTR-CM
-
FDA evaluates supplemental application for vutrisiran to treat patients with ATTR-CM
-
Tafamidis shows long-term benefits in slowing ATTR-CM progression
-
Study offers a snapshot of patients with ATTR-CM in Australia and New Zealand
-
Tafamidis reduced amyloid in ATTR-CM but showed no symptom improvement